ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Carol A. Fisher
Barbara Todd
Nina Stenach
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kappa, J. R.
Right arrow Articles by Addonizio, V. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kappa, J. R.
Right arrow Articles by Addonizio, V. P.

Ann Thorac Surg 1990;49:714-723
© 1990 The Society of Thoracic Surgeons

Articles

Intraoperative management of patients with heparin-induced thrombocytopenia

Jeffrey R. Kappa, MDa,b,1, Carol A. Fisher, BAa,b, Barbara Todd, MSN, CRNPa,b, Nina Stenach, CCPa,b, Patrice Bell, MSa,b, Fred Campbell, MDa,b, Norig Ellison, MDa,b, V.Paul Addonizio, MD*,a,b,2

a Departments of Surgery and Anesthesiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
b Berlex Laboratories, Inc, Wayne, New Jersey, USA

* Address reprint requests to Dr Addonizio, Department of Surgery, Temple University School ot Medicine, Broad and Ontario Sts, Philadelphia, PA 19140.

For 11 patients with confirmed heparin-induced thrombocytopenia, we used reversible platelet inhibition with iloprost, a stable prostacyclin analogue, to permit safe heparin administration for cardiac (n = 9) or vascular (n = 2) operations. In vitro, iloprost (0.01 µmol/L) prevented both heparin-induced platelet aggregation and 14C-serotonin release in all patients. Therefore, intraoperatively, a continuous infusion of iloprost was started before administration of heparin and was continued until 15 minutes after administration of protamine. For cardiac patients, after heparin administration, the whole Mood platelet count did not change (171,000 ± 29,000/gmL versus 174,000 ± 29,000/gmL, mean ± standard error of the mean); no spontaneous platelet aggregation was observed, and plasma levels of the α-granule constituents platelet factor 4 and β-thromboglobulin increased from 38 ± 14 and 140 ± 18 ng/mL to 591 ± 135 and 235 ± 48 ng/mL, respectively. Fibrinopeptide A levels actually decreased from 287 ± 150 to 27 ± 6 ng/mL. Furthermore, adenosine diphosphate-induced platelet activation was preserved, postoperative bleeding times wen unchanged, and no heparin-related deaths occurred. Similar results were obtained in both vascular patients. We conclude that temporary platelet inhibition with iloprost now permits safe heparin administration in all patients with heparin-induced thrombocytopenia who require a cardiac or vascular operation.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
A. L. Meyer, D. Malehsa, C. Kuehn, C. Bara, C. Gras, C. Hafer, A. Haverich, and M. Struber
HeartMate II Implantation in Patients With Heparin-Induced Thrombocytopenia Type II
Ann. Thorac. Surg., August 1, 2009; 88(2): 674 - 675.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
D Belway, F D Rubens, B Henley, A Babaev, and T Mesana
Delayed thrombin generation is not associated with fibrinopeptide formation during prolonged cardiopulmonary bypass with hirudin anticoagulation
Perfusion, September 1, 2006; 21(5): 259 - 262.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
F. D. Rubens, G. Lavalee, M. A. Ruel, T. Mesana, and M. Bourke
Delayed Thrombin Generation With Hirudin Anticoagulation During Prolonged Cardiopulmonary Bypass
Ann. Thorac. Surg., January 1, 2005; 79(1): 334 - 336.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
S. Tabata, S. Yamaguchi, H. Nagamine, S. Tomita, S. Arai, H. Takemura, and G. Watanabe
Efficacy of FK633, an ultra-short acting glycoprotein IIb/IIIa antagonist on platelet preservation during and after cardiopulmonary bypass
Eur J Cardiothorac Surg, August 1, 2004; 26(2): 289 - 293.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
G. M. Palatianos, C. N. Foroulis, M. I. Vassili, P. Matsouka, G. M. Astras, G. H. Kantidakis, E. Iliopoulou, and E. N. Melissari
Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost
J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 548 - 554.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
S. Kanemitsu, M. Nishikawa, K. Onoda, T. Shimono, H. Shimpo, A. Yazaki, K. Tanaka, H. Shiku, and I. Yada
Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation
J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 428 - 435.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. Aouifi, P. Blanc, V. Piriou, O. H. Bastien, P. Ffrench, M. Hanss, and J.-J. Lehot
Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia
Ann. Thorac. Surg., February 1, 2001; 71(2): 678 - 683.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
Y. Sun, P. E. Greilich, S. I. O. Wilson, M. R. Jackson, and C. W. Whitten
The Use of Lepirudin for Anticoagulation in Patients with Heparin-Induced Thrombocytopenia During Major Vascular Surgery
Anesth. Analg., February 1, 2001; 92(2): 344 - 346.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
F. Follis and C. A. Schmidt
Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis
Ann. Thorac. Surg., December 1, 2000; 70(6): 2173 - 2181.
[Abstract] [Full Text] [PDF]

Home page
 CLIN APPL THROMB HEMOSTHome page
R. L. Bick and E. P. Frenkel
Clinical Aspects of Heparin-Induced Thrombocytopenia and Thrombosis and Other Side Effects of Heparin Therapy
Clinical and Applied Thrombosis/Hemostasis, October 1, 1999; 5(1_suppl): S7 - S15.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
Y. Suzuki, P. Hillyer, S. Miyamoto, S. Niewiarowski, L. Sun, A. K. Rao, S. Hollenbach, and L. H. Edmunds Jr
Integrilin prevents prolonged bleeding times after cardiopulmonary bypass
Ann. Thorac. Surg., August 1, 1998; 66(2): 373 - 381.
[Abstract] [Full Text] [PDF]

Home page
 CLIN APPL THROMB HEMOSTHome page
J. M. Walenga, B. E. Lewis, D. A. Hoppensteadt, J. Fareed, and M. Bakbos
Management of Heparin-Induced Thrombocytopenia and Heparin-Induced Thrombocytopenia and Thrombosis Syndrome
Clinical and Applied Thrombosis/Hemostasis, October 1, 1997; 3(1_suppl): S53 - S63.
[Abstract] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
Y. Hiramatsu, N. Gikakis, H. L. Anderson III, J. H. Gorman III, C. Marcinkiewicz, R. J. Gould, S. Niewiarowski, and L. H. Edmunds Jr.
TIROFIBAN PROVIDES ""PLATELET ANESTHESIA"" DURING CARDIOPULMONARY BYPASS IN BABOONS
J. Thorac. Cardiovasc. Surg., January 1, 1997; 113(1): 182 - 193.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
M. J. Wilhelm, C. Schmid, D. Kececioglu, T. Mollhoff, H. Ostermann, and H. H. Scheld
Cardiopulmonary Bypass in Patients With Heparin-Induced Thrombocytopenia Using Org 10172
Ann. Thorac. Surg., March 1, 1996; 61(3): 920 - 924.
[Abstract] [Full Text]

Home page
 CLIN APPL THROMB HEMOSTHome page
R. Pifarre
State-of-the-Art Review: Optimal Anticoagulation in Cardiovascular Surgery
Clinical and Applied Thrombosis/Hemostasis, June 1, 1995; 1(3): 173 - 178.
[Abstract] [PDF]

Home page
 CLIN APPL THROMB HEMOSTHome page
J. M. Walenga, J. Fareed, R. L. Bick, and R. Pifarre
New Anticoagulants for the Cardiovascular Patient
Clinical and Applied Thrombosis/Hemostasis, January 1, 1995; 1(1): 24 - 30.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. Bernabei, N. Gikakis, M. A. Kowalska, S. Niewiarowski, and L. Henry Edmunds Jr
Iloprost and echistatin protect platelets during simulated extracorporeal circulation
Ann. Thorac. Surg., January 1, 1995; 59(1): 149 - 153.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S. W. Downing and L. H. Edmunds Jr
Release of vasoactive substances during cardiopulmonary bypass
Ann. Thorac. Surg., December 1, 1992; 54(6): 1236 - 1243.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1990 by The Society of Thoracic Surgeons.